Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Gliclazide
Aspen Pharma Pty Ltd
Medicine Registered
NIDEM- Consumer Medicine Information Page 1 of 4 Nidem gliclazide CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about NIDEM. It does not contain all of the available information. It does not take the place of talking to your doctor, pharmacist or diabetes educator. All medicines have benefits and risks. Your doctor has weighed the risks of you taking NIDEM against the benefits they expect it will have for you. TALK TO YOUR DOCTOR, PHARMACIST OR DIABETES EDUCATOR IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT NIDEM IS USED FOR NIDEM is used to control blood glucose in people with Type 2 diabetes mellitus. This type of diabetes is also called non-insulin dependent diabetes mellitus (NIDDM) or maturity onset diabetes. NIDEM is used when diet and exercise are not enough to control your blood glucose levels. It can be used alone, or in combination with other medicines for treating diabetes. NIDEM is available only with a doctor's prescription. HOW NIDEM WORKS NIDEM belongs to a group of medicines called sulphonylureas. These medicines lower blood glucose by increasing the amount of insulin produced by your pancreas. If your blood glucose is not properly controlled, you may experience hypoglycaemia (low blood glucose) or hyperglycaemia (high blood glucose). HYPOGLYCAEMIA Hypoglycaemia (low blood glucose) can occur suddenly. Signs may include: • weakness, trembling or shaking • sweating • lightheadedness, dizziness, headache or lack of concentration • irritability, tearfulness or Read the complete document
NIDEM- Product Information Page 1 of 5 Nidem PRODUCT INFORMATION NAME OF THE MEDICINE Gliclazide. The chemical name for gliclazide is 1-(3-azabicyclo[3.3.0] oct- 3-yl)-3-para- tolylsulfonylurea. Its structural formula is: O O O S N N N H H CH 3 C 15 H 21 N 3 O 3 S Molecular weight: 323.4 Cas No.: 21187-98-4 DESCRIPTION Gliclazide is a white or almost white powder, practically insoluble in water, freely soluble in dichloromethane, sparingly soluble in acetone and slightly soluble in ethanol 96%. Nidem tablets contain 80 mg of gliclazide. The tablets also contain the following excipients: lactose, microcrystalline cellulose, povidone, purified talc, sodium starch glycollate type A and magnesium stearate. The tablets are gluten free. PHARMACOLOGY Mode of action: Gliclazide stimulates insulin secretion from functional pancreatic beta-cells and increases the sensitivity of the beta-cells to a glucose stimulus (some residual beta-cell function is therefore necessary). Gliclazide restores the diminished first phase of insulin secretion noted in non-insulin dependent diabetes mellitus. Any long-term hypoglycaemic activity of gliclazide can be attributed to an ability to maintain its effect on insulin secretion. Extrapancreatic effects may also be involved in the long-term efficacy of gliclazide. Extrapancreatic effects demonstrated for gliclazide include improvement in insulin mediated glucose utilisation and potentiation of postreceptor insulin sensitive pathways. At normal therapeutic doses in humans, gliclazide reduces platel Read the complete document